All News

Patients with gastric cancer who present with certain bacteria in their gut were found to be more likely to experience skin-related side effects from Opdivo treatment, research showed.

The use of a non-invasive procedure combined with Lenvima plus Tyvyt demonstrated safe and effective results in patients with liver cancer not eligible for surgical resection.

A woman living with metastatic breast cancer describes how the death of a friend’s grandmother reminded her of her own grandmother’s passing and the lessons she learned about life from it that she applies in her cancer journey.

Researchers observed this benefit in recurrent HCC after liver transplantation, which represents a patient population often excluded from clinical trials due to potential organ rejection.

A patient with stage 4 ovarian cancer still receiving treatment six years after her first diagnosis explains that even though she’s exhausted from all her treatments and the related side effects, she knows many others don’t survive as long as she has.

Treating patients with liver cancer initially with Lenvima instead of the standard of care was associated with a survival benefit, according to recent research.

The use of a minimally invasive procedure — known as trans-arterial chemoembolization — plus Lenvima and a PD-1 checkpoint blockade drug proved to be safe and efficacious in patients with unresectable advanced liver cancer.

Lorelei Colbert was diagnosed with triple-negative breast cancer at 28 and used her experience to launch the “Chemo to Kindness” challenge that inspired others around the world to do acts of good.

A woman explains how she grapples with the acceptance that her sister may never enter remission from cancer.

The use of Enhertu was associated with a reduction in the risk of death compared with standard chemotherapy in certain patients with gastroesophageal and gastric cancer.

Researchers plan to enroll 60 patients in the first-in-human phase 1 clinical trial to assess the safety and preliminary clinical activity of an anti-CD39 monoclonal antibody to treat advanced solid tumors.

Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.

When trying to relate to a cancer survivor, do not tell them how someone else died of the disease, writes Michelle Velez.

A mother of a breast cancer survivor explains how she pinpoints the reasoning behind why a certain day might be extra difficult emotionally for her and how she deals with it.

In this episode of the “Cancer Horizons” podcast, a cervical cancer survivor and advocate explains how she navigated being given six to 24 months to live as a single mother of three children and no health insurance.

From when to replace masks to addressing a CDC-recommended strategy to improve the effectiveness of surgical masks, Dr. Tatiana M. Prowell of Johns Hopkins Medicine offers masking tips for patients with cancer.

A woman living with metastatic breast cancer shares how her relationship with her sister who was adopted from Korea transformed after they both received a cancer diagnosis.

After promising phase 3 clinical trial results, the FDA will consider Libtayo for approval to treat patients with advanced non-small cell lung cancer, regardless of PD-L1 status.

A new study to evaluate the accuracy of a blood test for detecting lung cancer in high-risk adults has enrolled its first participant with plans to enroll thousands more.

A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.

A survivor of breast cancer explains what she has learned about inclusive language and how it can empower patients who have been diagnosed with cancer on their healing journey.

The FDA will speed up their review of CYNK-101 plus chemotherapy and immune checkpoint inhibitors for the treatment of advanced HER2-postivie gastric or gastroesophageal adenocarcinomas.

The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.

Prostate cancer survivors are encouraged to include their partners in interventions to improve sexual function after treatment — and, as study results show, it is better to have these conversations with providers sooner rather than later.

After the drug showed promising results in the DESTINY-Breast03 trial, the FDA granted Enhertu a priority review, meaning that it plans to make its approval decision on it by the end of the second quarter of 2022.

One breast cancer survivor shares the experience she had with her daughters in trying to get them to understand the importance of participating in preventive screenings.

The survey results also showed that those who have received a cancer diagnosis have faced more setbacks when it comes to working during the pandemic.

One woman explains how after experiencing irregular bleeding, she found out she had cervical cancer and her life changed immediately.